IBO CIK: 1834105

Impact BioMedical Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−2.24
FY23:
−2.85
FY24:
−2.85
FY25:
−1.89
Change from FY21 to FY25
millions USD
FY21:
−0.35
FY22:
−0.35
FY23:
−0.02
FY24:
0.00
FY25:
0.00
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
2.55
FY23:
2.87
FY24:
4.85
FY25:
−0.11
millions USD
FY21:
–
FY22:
−0.04
FY23:
0.00
FY24:
2.00
FY25:
−2.00

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data